Rossari Biotech posts Q1 FY25 consolidated PAT at Rs. 34.89 Cr
General

Rossari Biotech posts Q1 FY25 consolidated PAT at Rs. 34.89 Cr

Rossari Biotech has reported total income of Rs. 490.59 crores during the period ended June 30, 2024

  • By ICN Bureau | July 21, 2024

Rossari Biotech Limited has reported consolidated financial results for the period ended June 30, 2024.

Rossari Biotech has posted net profit of Rs. 34.89 crores for the period ended June 30, 2024 as against net profit of Rs. 34.13 crores for the period ended March 31, 2024. The company posted net profit of Rs. 29.21 crores for the period ended June 30, 2023.

Rossari Biotech has reported total income of Rs. 490.59 crores during the period ended June 30, 2024 as compared to Rs. 473.10 crores during the period ended March 31, 2024. The company reported total income of Rs. 412.79 crores during the period ended June 30, 2023.

Upcoming E-conferences

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization